Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223

Radium-223 dichloride (Ra223) represents the unique bone-directed treatment option that shows an improvement in overall survival (OS) in metastatic castrate resistant prostate cancer (mCRPC). However, there is an urgent need for the identification of reliable biomarkers to non-invasively determine i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2019-12, Vol.12 (1), p.31
Hauptverfasser:	Bauckneht, Matteo, Capitanio, Selene, Donegani, Maria Isabella, Zanardi, Elisa, Miceli, Alberto, Murialdo, Roberto, Raffa, Stefano, Tomasello, Laura, Vitti, Martina, Cavo, Alessia, Catalano, Fabio, Mencoboni, Manlio, Ceppi, Marcello, Marini, Cecilia, Fornarini, Giuseppe, Boccardo, Francesco, Sambuceti, Gianmario, Morbelli, Silvia
Format:	Artikel
Sprache:	eng
Schlagworte:	Alkaline phosphatase Avidity Bone cancer Bone lesions Cancer therapies Castration Chemotherapy Computed tomography Glycolysis L-Lactate dehydrogenase Lactic acid Medical imaging Metabolic disorders Metabolic response Metastases Metastasis Patients Positron emission tomography Prostate cancer Prostate-specific antigen Questioning Radium Scintigraphy Solid tumors Tomography Variables
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!